|
SERF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.553580E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.533000E-01 |
| Normal-vs-Stage2 |
1.560980E-01 |
| Normal-vs-Stage3 |
1.697860E-02 |
| Normal-vs-Stage4 |
2.632700E-04 |
| Stage1-vs-Stage2 |
9.921600E-02 |
| Stage1-vs-Stage3 |
4.576700E-03 |
| Stage1-vs-Stage4 |
7.7313999999995E-05 |
| Stage2-vs-Stage3 |
8.943600E-01 |
| Stage2-vs-Stage4 |
2.856000E-01 |
| Stage3-vs-Stage4 |
9.118000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.022760E-01 |
| Normal-vs-AfricanAmerican |
1.579610E-03 |
| Normal-vs-Asian |
9.176400E-01 |
| Caucasian-vs-AfricanAmerican |
8.040100E-03 |
| Caucasian-vs-Asian |
6.641200E-01 |
| AfricanAmerican-vs-Asian |
1.944190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.744100E-02 |
| Normal-vs-Female |
9.090000E-02 |
| Male-vs-Female |
9.266400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.089240E-01 |
| Normal-vs-Age(41-60Yrs) |
5.231500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.834160E-01 |
| Normal-vs-Age(81-100Yrs) |
1.406030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.015400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.059800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.915800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.493600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.981000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.205600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.489600E-01 |
| Normal-vs-Grade 2 |
6.230000E-01 |
| Normal-vs-Grade 3 |
1.206230E-02 |
| Normal-vs-Grade 4 |
2.217700E-04 |
| Grade 1-vs-Grade 2 |
9.060800E-01 |
| Grade 1-vs-Grade 3 |
9.802000E-02 |
| Grade 1-vs-Grade 4 |
1.541670E-03 |
| Grade 2-vs-Grade 3 |
6.725000E-03 |
| Grade 2-vs-Grade 4 |
1.381700E-04 |
| Grade 3-vs-Grade 4 |
1.400390E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.157700E-03 |
| Normal-vs-ccB subtype |
2.836200E-02 |
| ccA subtype-vs-ccB subtype |
1.98149999999231E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.000180E-01 |
| Normal-vs-N1 |
6.455900E-02 |
| N0-vs-N1 |
1.370240E-01 |
|
|
